跳至主要内容
临床试验/NCT06414694
NCT06414694Enrolling By Invitation4 期

Inpatient Penicillin Delabeling for Low-Risk Patients

University of Tennessee2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
入组人数
25
试验地点
2
主要终点
Direct Oral Challenge

研究概览

简要总结

This study seeks to enroll patients admitted to a children's hospital with identified penicillin allergy. A screening checklist is performed to identify patients with very low or low risk histories of penicillin allergy to offer direct oral challenges to the antibiotic class to de-label patient's with drug allergies.

详细描述

This is a pilot study looking to utilize a novel criterion to identify low risk penicillin allergies for patients admitted to a children's hospital to evaluate safety and efficacy of direct oral challenges to patients with very low or low risk histories as identified in novel criterion.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >2 years
  • Patients identified via EMR as having a penicillin, amoxicillin, amoxicillin/clavulanic acid allergy

排除标准

  • Female patients aged >8 years of age
  • Patients with hemodynamic instability
  • Patients identified with moderate or high risk histories per protocol
  • Patients currently taking oral antihistamines in 48 hours prior to direct challenge
  • Patients currently taking oral steroids in 48 hours prior to direct challenge
  • Patients currently receiving medications for nausea, shortness of breath,

结局指标

主要结局

Direct Oral Challenge

时间窗: 2 hours

Pass or Failure of direct oral challenge

次要结局

  • Follow-up at 48(48 hours)
  • Follow-up at 6 months(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Inpatient Penicillin Delabeling for Low-Risk Patients | 临床试验